INTRODUCTION
============

mtDNA (mitochondrial DNA) in *Saccharomyces cerevisiae* S288C contains nine group I introns: four in *COB* (cytochrome *b*), four in *COX1* (cytochrome *c* oxidase subunit 1) and one in *21S R_RNA* \[[@B1]\]. Group I introns, so-called 'molecular parasites' or 'infectious introns', are widespread mobile elements whose removal at RNA level is crucial for their own survival \[[@B2],[@B3]\]. Although they self-splice *in vitro*, additional factors are required to assist this process *in vivo* \[[@B2]--[@B4]\]. Specific and non-specific nuclear-encoded proteins are required for splicing. For instance, Mss116p assists the splicing of all mtDNA introns \[[@B5]\], while Mne1p is only responsible for *COX1* aI5β intron removal \[[@B6]\]. Intron-encoded proteins, known as maturases, are involved in the removal of at least the same intron that codes for them. Maturase mRNAs comprise part of the mature mRNA in the form of preceding exons and a large part of the intron to be removed \[[@B4]\]. Particularly, translation of the ORF (open reading frame) composed of the first four *COB* exons and part of the fourth intron \[bI4 (*COB* fourth intron)\] generates bI4 maturase. This protein participates in the excision of bI4 and aI4 (*COX1* fourth intron) of their pre-mRNAs \[[@B7]\]. Selective pressure drives the maturases to recruit pre-existing nuclear-encoded proteins with non-related functions to assist splicing \[[@B1],[@B3]\]. These factors, by acquiring a second function, become moonlighting proteins \[[@B8]\]. For instance, Pet54p participates in the excision of aI5β \[[@B9]\], but it is also required for translation of *COX3* mRNA \[[@B10]\]. Both activities reside in a shared RNA-binding region \[[@B11]\]. Nam2p, a mitochondrial leucyl-tRNA synthetase is also involved in bI4 mitochondrial RNA splicing activity \[[@B12],[@B13]\]. Ccm1p was reported to be essential for the removal of bI4 and aI4 \[[@B14]\], as well as with Nam2p \[[@B15]\]. Ccm1p has two PPR (pentatricopeptide repeat) motifs in tandem, located between amino acids 319 and 353 and amino acids 356 and 390 \[[@B16]\]. Both domains are required for activity \[[@B14]\]. The PPR family is composed of three degenerated domains that span between 31 and 36 amino acids \[[@B17]\]. PPR motifs occur in tandem arrays of 2--26 units per protein \[[@B18]\]. Each motif is predicted to comprise two anti-parallel α-helices that contain several projecting amino acidic side groups; therefore the arrays would form a superhelix with a binding surface that is suitable to interact with selected bases \[[@B19]\] and phosphate groups of RNA molecules \[[@B20]\]. PPR proteins bind to specific RNA sequences \[[@B21]\] and mainly participate in post-transcriptional events, such as RNA editing \[[@B22]\], translation \[[@B23]\], stability \[[@B21]\], processing \[[@B24]\] and splicing \[[@B14]\]. Further studies proved that Ccm1p was also required to maintain the ribosomal RNA of the small subunit (15S rRNA) in *S. cerevisiae* intronless mitochondria \[[@B25]\] and intron-containing mitochondria strains (in this study). Even though we had detected 15S rRNA by end-point PCR in nascent non-complemented Δ*ccm1* segregants, it was not clear that such levels were above the threshold at which the translational machinery was functional \[[@B14]\]. In addition, a recent report suggested that a PPR protein of fission yeast that belongs to the *CCM1* family, Ppr3 \[[@B16]\] also stabilizes 15S rRNA \[[@B26]\]. These facts created a dilemma of whether Ccm1p directly participates in bI4 intron removal along with bI4 maturase, or supports the latter by stabilizing 15S rRNA, thus keeping the translational machinery functional. We undertook this work to answer the aforementioned question. Our results demonstrate, by three independent lines of evidence, that these two Ccm1p activities are independent of one another. Thus Ccm1p, a heretofore unrecognized bi-functional PPR protein is, under an operational standpoint, a crucial factor that assists bI4 maturase activity and moonlights by keeping steady-state levels of mitochondrial 15S rRNA. Furthermore, lysine-conferred positive charges in the second PPR motif are required for fully efficient splicing activity but not for maintenance of 15S rRNA. Results presented in this paper exhibit the potential to tightly manipulate Ccm1p levels in order to study the pathway followed by 15S rRNA during mitoribosome assembly.

EXPERIMENTAL
============

DNA constructs
--------------

A 2 μm-based vector that harbours the *CCM1* ORF fused at the N-terminus to a ZZ affinity tag under the control of the *GAL1* promoter (pCCM1ZZ) was purchased from Open Biosystems. A 5.5-kb DNA fragment, which contained the CCM1ZZ expression cassette plus 500 bp upstream and 1000 bp downstream of additional sequences, was produced by LguI (Fermentas) digestion. The 5′ protruding ends of this gel-purified DNA fragment were blunted with Klenow DNA polymerase (New England BioLabs) and ligated to the SmaI sites of pRS316, a low copy vector (pCCM1ZZLC). The low copy vector expressing the authentic *CCM1* ORF (pCCM1LC) was obtained as previously described \[[@B14]\].

The three lysines in PPR2, Lys^369^, Lys^375^ and Lys^389^ were mutated to alanine. A 500-bp DNA fragment flanked by HindIII and SacI sites in *CCM1* ORF that contained the mutated PPR2 was synthesized by DNA 2.0. The HindIII/SacI synthetic 500-bp DNA fragment was then swapped for its 500-bp wild-type counterpart in the *CCM1* ORF which had been previously subcloned into pYC2/CT (Invitrogen). This new construct is referenced as pCCM1AAA throughout this study.

The short form of bI4 maturase, which only contained the last 254 amino acids at the C-terminal end, was synthesized by DNA 2.0, with the following modifications: five mitochondrial TrpTGA codons were changed to TrpTGG for cytoplasmic synthesis and the 12-amino acid signal peptide from a 70 kDa mitochondrial protein was fused to the N-terminus to enable mitochondrial import. The 800-bp BamHI/XhoI-flanked DNA fragment was inserted into the expression vector pYC2/CT, and named pbI4MAT. bI4 maturase expression was monitored by SDS/PAGE and Western blotting using pAb (polyclonal antibody) II (see ELISA section).

Media and strains
-----------------

Yeast media were prepared as previously indicated \[[@B14]\]. The *S. cerevisiae* wild-type BY4741 strain (B) (*MAT*a *ura3*Δ0 *leu2*Δ0 *his3*Δ1 *met15*Δ0) was a generous gift from Dr Dennis R. Winge (Departments of Medicine and Biochemistry, University of Utah, Health Science Center, Salt Lake City, UT, U.S.A.). *S. cerevisiae* harbouring intronless mitochondria (I^0^) (*MAT*a *ade1*Δ0 *lys1*Δ0 *ura3*Δ0) was kindly provided by Dr Alan M. Lambowitz (Institute for Cellular and Molecular Biology, Departments of Chemistry, Biochemistry and Microbiology, University of Texas at Austin, TX, U.S.A.). B and I^0^ were mated with Δ*ccm1* (*MAT*α *ura3*Δ0 *leu2*Δ0 *his3*Δ1 *lys*Δ0 *ccm1*Δ0::*kanMX*) from Invitrogen to generate 2nB and 2nI heterozygous diploids respectively, which carry functional mitochondria. Yeast manipulation, including selection of heterozygous strains, maintenance and transformation, sporulation, tetrad dissection and further analysis of meiotic segregants were performed as described \[[@B14]\]. Δ*ccm1* segregants complemented by pCCM1LC, pCCM1ZZLC, or pCCM1AAA were stored in rich medium \[YEP (yeast extract peptone)\] with glycerol and G418 or uracil free-SD (synthetic defined) medium with glycerol at 4°C for not longer than 3 weeks.

DNA, RNA and protein analysis
-----------------------------

Nucleic acid isolation and Northern blotting were performed as previously described \[[@B14]\]. mtDNA levels were assessed by qPCR (quantitative PCR) using *COX1* \[[@B14],[@B27]\] and *15S\_ RRNA* as mtDNA markers and *ACT1* as nuclear marker in the Smart Cycler II thermal cycler (Cepheid). For Northern blotting, the 15S rRNA probe spanned 204 bp from position 654 to 857. Signals were visualized and photographed with a gel documentation system (FluorChem SP, Alpha Innotech Corporation). Levels of mitochondrial rRNAs, *ACT1*, *CCM1* and immature *COB* (exon 4--intron 4 boundary) transcripts as well as maturase activity were determined by RT-qPCR (reverse transcription-qPCR) ([Table 1](#T1){ref-type="table"}). bI4 maturase activity was determined by priming at either *COB* or *COX1* exon 4--exon 5 boundary \[[@B14]\]. Calibration curves converted *C*~t~ (threshold cycle value) into starting amounts of template for each qPCR template--primers combination. DNA templates were obtained by purifying amplicons from end-point PCR or qPCR with the QIAEXII kit (Qiagen) following the manufacturer\'s instructions, and confirmed by both *T*~m~ (melting temperature) and restriction analysis. Their concentrations were determined spectrophotometrically. The slope and *R*^2^ value of each calibration curve were calculated with the SigmaStat statistical software (SPSS). *R^2^* values were at least 0.994. Primer sequences, annealing positions and amplicon size are indicated in [Table 1](#T1){ref-type="table"}. For SDS/PAGE and Western blotting \[[@B28]\], yeast crude extracts were prepared in the presence of lysis buffer \[130 mM EDTA, 130 mM EGTA, one tablet of Complete Protease Inhibitor (Santa Cruz Biotechnology) per ml and 2×Protease Inhibitor Cocktail (Sigma--Aldrich) in 1×PBS\]. Cells were mechanically disrupted with 0.5 mm diameter glass beads for 2 min at room temperature (25°C) using a cell disruptor (Scientific Industries). Triton X-100 was then added up to 1% and disruption continued for an additional 2 min. Crude extracts were then clarified by centrifugation at 4°C for 5 min at 20000 ***g***. Total protein contents were determined using the Bradford assay and BSA as standard (Thermo Fisher Scientific).

###### Primers used in the present study

  Gene      Forward primer (F) (5′→3′)   Reverse primer (R) (5′→3′)   Amplicon size (bp)   F/R annealing position
  --------- ---------------------------- ---------------------------- -------------------- ------------------------
  ACT1      GGTACCACCATGTTCCCAGG         AACCACCAATCCAGACGGAG         127                  904--923, 1011--1030
  21S       CGGGTCCCGGAACTTAAATA         CGAGGTGGCAAACATAGCTT         221                  2548--2567, 2553--2768
  COBE4I4   TTCCAATGCATTCATACTTTATTTTT   AAGATTTCCAGCATACAGCACA       168                  658--681, 802--823
  bI2       TGGACAGATGTCACATTGAGG        CGTTACCTACAAATGGAATTGCT      71                   408--428, 456--478
  bI3       TCTCAGCAATTCCATTTGTAGG       TGCCATTAAATGCATAATAACCA      149                  452--473, 578--600
  15S       GTTAAACCTAGCCAACGATCCA       TGTCCAATATTCCTCACTGCTG       108                  270--291, 356--377
  CCM1      CCAAACCTGAGACCACGGA          TAGCGGCTTTCATCACCAGCTC       120                  2126--2144, 2224--2245
  COX1E4    CTACAGATACAGCATTTCCAAGA      GTGCCTGAATAGATGATAATGGT      146                  270--291, 393--415
  bI4       AGGAGGTGGTGACCCAATCT         AATCCAATTGAAGCCATAGCA        174                  672--691, 825--845

Time-course experiments
-----------------------

For mtDNA studies, 56 colonies (approximately 25 generations from a single cell) of Δ*ccm1* non-complemented nascent meiotic segregants from 2nI or 2nB were harvested from YEP with galactose master plates and pooled. A fraction of the cells (1/200) were used to inoculate fresh YEP with dextrose and subsequent cultures. The remaining cells represented the initial time point (*t*=0). Over 4 days, changes in the mitochondrial genome were monitored every 24 h as Ccm1p and functional mitochondria were diluted along with the progression of cell division.

For SMDC (sudden mitochondrial deprivation of Ccm1p), complemented Δ*ccm1* segregants that carried pCCM1LC or pCCM1ZZLC were initially checked for mitochondrial functionality by growth in the presence of glycerol, ethanol, or lactate as sole source of carbon and energy. *CCM1* expression in those complemented segregants harbouring pCCM1LC or pCCM1ZZLC was fully induced by growing them in SD with galactose for 16 h. Those complemented segregants that exhibited tightest regulation of Ccm1p expression were selected for these studies. Aliquots, representing *t*=0, were collected and stored at −70°C for further analysis. The rest of the cells were washed three times with sterile, deionized water at room temperature, and *CCM1* repression by glucose was carried out by inoculating SD with dextrose as follows: 1:1 for 1 and 2 h; 1:2 for 3 h; 1:4 for 6 h; 1:6 for 12 h; 1:16 for 24 h; 1:100 for 48 and 96 h. Aliquots were harvested at the different incubation times and processed as indicated below.

bI4 maturase protein measurement by ELISA
-----------------------------------------

The peptide epitopes LNTKQLNNFVLKFNWTKQ (I) and CPSKSNKGKRLFLIDKF (II) present in the bI4 intron-encoded maturase moiety were designed, synthesized and purified by 21st Century Biochemicals. The peptides were analysed by nanospray MS and HPLC analysis and the sequence verified by collision-induced dissociation MS/MS (tandem MS). Rabbit pAbs against these peptides, pAbI and pAbII respectively, were produced and affinity-purified by 21st Century Biochemicals. The capture antibody (pAbI) concentration was standardized for maximal signal at 40 ng/100 μl per well. The reporter antibody (pAbII) was biotinylated as follows: 0.2 mg of affinity purified antibody was mixed with 2 mg of sodium *meta*-periodate in 1 ml of 0.1 M sodium acetate buffer, pH 5.5. The antibody carbohydrate residues were thus oxidized for 1 h at room temperature in the dark. The oxidation mixture was then changed to PBS (0.1 M sodium phosphate and 0.15 M NaCl, pH 7.2) using a 2 ml-Zeba Desalt Spin Column (Thermo Fisher Scientific). Then 0.9 ml of antibody-containing effluent was combined with 0.1 ml of 50 mM EZ-link biotin hydrazide in DMSO (Thermo Fisher Scientific) and incubated for 2 h at room temperature. Biotinylated pAbII was separated from free biotin by passing the reaction mixture through a PBS equilibrated-2 ml Zeba Desalt Spin Column. The biotinylated pAbII was stored at 4°C in the presence of 0.01% thimerosal. Maximal signal for the biotinylated reporter pAbII was obtained at a 1:5000 dilution of the final preparation indicated above. Streptavidin poly-HRP (horseradish peroxidase) (Thermo Fisher Scientific) was used as a 1:5000 dilution of the stock solution (0.5 mg/ml). The reaction was developed with TMB (3,3′,5,5′-tetramethylbenzidine) One Component HRP Microwell Substrate (BioFX Laboratories) and stopped with 0.5 M sulphuric acid. Absorbance at 414 nm was measured using a Multiskan EX ELISA reader (MTX Lab Systems).

Yeast crude extracts were prepared by resuspending cell pellets that had been stored at −70°C in lysis buffer as described for SDS/PAGE and Western blotting samples. Then 120 μg of protein in 100 μl were serially diluted 1:2 with 100 μl of DB (dilution buffer: lysis buffer plus 1% Triton X-100, 0.1% Tween 20 and 0.5% BSA) in pAbI-coated 96-well Costar ELISA plates (Corning) and incubated at 4°C for 18 h. After three washes with WB (washing buffer: 1% Triton X-100 and 0.1% Tween 20 in 1×PBS), 100 μl of biotinylated pAbII in DB was added per well. Plates were then incubated at 4°C for 18 h. Wells were then washed three times with WB followed by incubation with 100 μl of Streptavidin Poly-HRP in DB for 2 h at room temperature. After the wells were washed three times with WB, followed by three washes with 0.05% Tween 20 in 1×PBS, reactions were developed and processed as indicated above.

Statistical analysis
--------------------

All qPCR values represent the means±S.E.M. of two or three replicates from the number of independent experiments indicated in each Figure legend. Time course results (amount of target mRNA over *ACT1* mRNA or target gene over *ACT1*) were expressed as a percentage of the value obtained at *t*=0 (control). RT-qPCR data were analysed by one-way ANOVA followed by Dunnett\'s *post hoc* test for multiple comparisons with the control group (SPSS). The strength of association between the relative levels of *CCM1* mRNA and bI4 maturase activity or 15S rRNA levels was measured with the Pearson Product Moment Correlation. Values of target mRNA from cells harbouring pCCM1AAA were compared with those of the wild-type plasmid using the Student\'s *t* test.

RESULTS AND DISCUSSION
======================

Intron-containing mtDNA cells became rho^**−**^ mutants dramatically faster than their intronless counterparts
--------------------------------------------------------------------------------------------------------------

We have determined the rate of mtDNA decay with which nascent non-complemented Δ*ccm1* meiotic segregants from 2nB (B cells) and 2nI (I^0^ cells) diploids became rho^−^ mutants. After being cytoplasmically inherited by the segregants, Ccm1p and functional mitochondria were diluted as cell proliferation progressed \[[@B14]\]. At *t*=0, relative levels of mtDNA in B segregants as determined by *15S\_ RRNA* and *COX1* \[[@B27]\] were 0.5 and 1.5 orders of magnitude lower than those of their I^0^ counterparts respectively ([Figure 1](#F1){ref-type="fig"}A). No decrease in mtDNA levels was detected in I^0^ segregants over the particular time-frame of this experiment. However, further reductions were observed in B cells, in which mtDNA levels were 0.5 (*15S\_ RRNA*) and 1 (*COX1*) order of magnitude lower at *t*=96 h than the corresponding levels at *t*=0. Overall, these results agree with our previous observations in B cells \[[@B14]\]. Another comparable case is *NAM1*, a gene involved in intron removal from *COB* and *COX1* pre-mRNAs which, when deleted, generated a large proportion of rho^−^ cells in strains with intron-containing genomes, while strains with intronless mtDNA showed a normal pattern of mitochondrial translation and kept their genomes intact \[[@B29],[@B30]\]. Therefore the presence of introns makes mtDNA stability significantly more Ccm1p-dependent than the intronless mtDNA counterpart regardless of the 15S rRNA steady-state levels (see below). This is a first line of evidence showing that Ccm1p plays a key role in *COB* and *COX1* mRNA maturation independently from 15S rRNA. Ccm1p deletion did not affect transcription or stability of *COB* and *COX1* mRNAs in I^0^ cells at early stages, before the mutant phenotype was established ([Figure 1](#F1){ref-type="fig"}B). Therefore changes in the mature or spliced *COB* mRNA levels were considered exclusively due to changes in the splicing activity (see below). A slight but consistent increment in their molecular mass was observed when Ccm1p was lost. This observation could mean that Ccm1p is directly or indirectly involved in another putative RNA processing function, similar to that of Cbt1p \[[@B31]\]. However, further studies will be required to demonstrate such activity.

![Differential deletion rate of mtDNA\
(**A**) Relative levels of intron-containing (B) and intronless (I^0^) mtDNA were assessed in nascent non-complemented Δ*ccm1* segregants by qPCR using *COX1* and *15S\_ RRNA* as mtDNA markers and *ACT1* as housekeeping gene. Results are means±S.E.M. of four independent experiments measured in duplicate. (**B**) 5 μg of total RNA from non-complemented nascent I^0^ segregants was analysed by Northern blotting using a *COB* E4-E5 or a *COX1* E4 probe. *CCM1*: wild type; Δ*ccm1*: mutant.](bsr347i001){#F1}

SMDC
----

By the time non-complemented nascent Δ*ccm1* segregants reached *t*=0 ([Figure 1](#F1){ref-type="fig"}A), the levels of the molecular targets were too low to be analysed \[[@B14]\]. Repression of the *GAL1* promoter by dextrose in pCCM1LC was enough to cause deficient growth in non-fermentable substrates \[[@B14]\], but a more stringent mitochondrial deprivation of Ccm1p was required to dissect events at the molecular level. Limitations upon *GAL1*-repression were previously reported \[[@B12],[@B32]\]. We approached the '*en route* trapping' import strategy of delta^1^-pyrroline-5-carboxilate dehydrogenase that fused the SPA (staphylococcal protein A) at its C-terminus \[[@B33]\]. Thus, complemented Δ*ccm1* segregants were subjected to SMDC by: (i) repressing Ccm1p expression with dextrose (*t*=0) and (ii) *en route* constraining mitochondrial import of Ccm1p by fusing two synthetic IgG-binding domains of SPA (ZZ) to the C-terminus of *CCM1* ORF (pCCM1ZZLC), thus delaying the import of the remaining protein whose expression has already been repressed. Northern blot analyses of *COB* mRNA from B Δ*ccm1* segregants, and 15S rRNA from B and I^0^ cells were conducted to validate SMDC. After 24 h of SMDC, mature *COB* mRNA levels noticeably decreased ([Figure 2](#F2){ref-type="fig"}A). By 48 h, mature *COB* mRNA was already undetectable but precursor forms were still visible. These results were entirely equivalent to those obtained with nascent non-complemented Δ*ccm1* segregants \[[@B14]\]. 15S rRNA levels also substantially diminished although the transcript was detectable at 48 h in both segregants ([Figure 2](#F2){ref-type="fig"}B). Under these conditions, levels of 21S rRNA in both wild-type and mutant as well as levels of 15S rRNA in wild-type were not reduced. Therefore any unspecific pleiotropic suppressive effect of dextrose on *COB* and 15S rRNA transcription \[[@B34]\] was ruled out. In contrast with the difference in mtDNA stability, RT-qPCR analysis of the samples described in [Figure 2](#F2){ref-type="fig"}(C) revealed that B and I^0^ Δ*ccm1* segregants experienced the same 15S rRNA decay rates, reaching 3.0±0.9% of the initial values at 48 h.

![Assessment of SMDC in B and I^0^ complemented Δ*ccm1* segregants\
(**A**) Splicing failure in *COB* mRNA due to Ccm1p loss. A portion (15 μg) of total RNA from B segregants was analysed by Northern blotting using a *COB* E4--E5 probe. (**B**) Ccm1p (Ccm1p-zz) monitored in 10 μg of clarified crude extracts by immunoblotting with an antibody against Ccm1p \[[@B14]\]. 15S rRNA assessment by Northern blotting of 5 μg of total RNA from the same samples using 15S rRNA and 21S rRNA probes. (**C**) Decay rate of 15S rRNA measured by RT-qPCR in I^0^ and B segregants. Results are means±S.E.M. of duplicate measurements.](bsr347i002){#F2}

SMDC reduced bI4 maturase activity significantly faster than 15S rRNA levels and boosted bI4 maturase synthesis
---------------------------------------------------------------------------------------------------------------

After 3 h of SDMC, bI4 maturase activity decreased more than 0.5 orders of magnitude below the initial value at *t*=0 (*P*\<0.05; [Figure 3](#F3){ref-type="fig"}A), reaching practically zero at 48 h. However, no significant difference in 15S rRNA levels was detected at either 3 or 6 h in comparison with the value at *t*=0 (*P*\>0.05). Additional factors might be interacting with 15S rRNA and thus ameliorating the SMDC effect. As Ccm1p is reportedly not part of the ribosome \[[@B35]\], it might be considered an RNA chaperone/carrier that protects and/or delivers 15S rRNA for assembly of the small subunit. This precise function has its human counterpart GTPase ERAL1 protein \[[@B36]\]. However, the role of Ccm1p as 15S rRNA transcription factor cannot be ruled out yet. Actually, a previous report states that human mitochondrial RNA polymerase has also two PPR motifs in tandem, located between amino acids 263--296 and 297--330; when deleted, the polymerase cannot initiate transcription \[[@B37]\]. That bI4 maturase activity drop preceded the 15S rRNA decay (see also [Figures 2](#F2){ref-type="fig"}(A) and [2](#F2){ref-type="fig"}(B), lanes 48 h in Δ*ccm1* segregants) clearly indicated that the failure in the activity of bI4 maturase was not due to a translation malfunction. Moreover, bI4 intron removal was shown to be significantly more Ccm1p-dependant than the maintenance of 15S rRNA steady-state levels. The strong statistical association detected between relative levels of *CCM1* mRNA and bI4 maturase activity (correlation coefficient=0.988, *P=*0.01) also confirmed a direct assistance of Ccm1p on bI4 maturase activity. Interestingly, *in vitro* experiments reported limited efficiency in the removal of the naturally occurring, full-size bI4 intron (\~1600 nt) by a Nam2p--bI4 maturase--RNA ternary complex \[[@B38]\]. Ccm1p would perfectly fit this scenario as a factor that assists the full-length bI4 intron in acquiring the competent structure towards a catalytic form. Finally, the activities of bI2 and bI3 maturase partially declined, but recovered at 24 h as did 21S rRNA levels ([Figure 3](#F3){ref-type="fig"}B and inset), but not those of 15S rRNA. This 'pit-shape' pattern was most likely due to repression of mitochondrial transcription by dextrose \[[@B39]\].

![Dissection of bI4 maturase and 15S rRNA stabilizing activities by SMDC\
(**A**) Differential reduction of bI4 maturase activity in comparison with 15S rRNA decay. Annealing position of each primer is symbolized by a horizontal arrow (inner panel). \*\**P*\<0.01 compared with corresponding values a *t*=0. (**B**) The comparative activities of bI2, bI3 and bI4 maturase were determined by their respective spliced forms. The annealing position of the primers (horizontal arrows) and 21S rRNA levels (open squares) are depicted in inner panels (I) and (II) respectively. Relative values (target mRNA/*ACT1* mRNA) are presented as a percentage of *t*=0, which were as follows: 15S rRNA (8012±688), bI4 maturase activity (11.5±1.9), bI2 maturase activity (12.5±0.5), bI3 maturase activity (21.0±1.8) and *CCM1* (82.0±34.6). Results are means±S.E.M. of duplicate or triplicate measurements from four or five independent pCCM1ZZLC-complemented B Δ*ccm1* segregants. (**C**) Boosts of bI4 maturase synthesis measured by ELISA along with concomitant loss of bI4 maturase activity. Priming to measure bI4 maturase mRNA is indicated in the left inner panel. bI4 maturase activity data in (**B**) and (**C**) are identical with (**A**) and were included for comparative purposes. (**D**) Immunoblot analysis of the first boost in bI4 maturase synthesis. A portion (10 μg) of clarified crude extract from I^0^ cells (lane 1), pCCM1LC-complemented B Δ*ccm1* segregant before starting SMDC (*t*=0, lane 2), or after 3 and 6 h in SMDC status (lanes 3 and 4 respectively) were resolved by SDS/12% PAGE, transferred and probed with antibody against epitope II. Arrowhead: \~75 kDa corresponding to full-length bI4 maturase. For (**A**) and (**B**), results are presented on a linear scale plot to document in a clearer manner that dissection of the two activities takes place between 0 and 12 h.](bsr347i003){#F3}

Cytoplasmic expression and import of bI4 maturase by Δ*ccm1* segregants were performed as previously described \[[@B7]\], but it failed to remove the bI4 intron. This observation hinted that, without Ccm1p, bI4 maturase was present but inactive. Since an active bI4 maturase eliminates its own mRNA (i.e. the mRNA precursor to synthesize Cob1p), under SMDC conditions, bI4 maturase mRNA should accumulate, thus increasing bI4 maturase synthesis. In agreement with this rationale, we found that at *t*=3 h, bI4 maturase synthesis was boosted \~4-fold ([Figure 3](#F3){ref-type="fig"}C) with respect to *t*=0. Furthermore, relative levels of bI4 maturase protein remained at least two-times higher during the entire experimental timeframe. The boost in maturase levels along with a concomitant drop in activity ([Figure 3](#F3){ref-type="fig"}A) rules out that SMDC increased maturase stability. Surprisingly, a second and even larger boost of bI4 maturase synthesis was detected at *t*=72 h when 12% of 15S rRNA remained, after a progressive accumulation of its own mRNA (i.e. the first four exons of *COB* mRNA and part of bI4), indicating that *de novo* protein synthesis took place at later SMDC stages. As a matter of fact, we have never observed that 15S rRNA levels were reduced to 0 during the timeframe of all our present and previously reported experiments \[[@B14]\]. It has long been accepted that both rRNAs and ribosomal proteins are readily degraded unless they are incorporated into a ribosomal subunit \[[@B40]\]. Shorter SMDC times showed that the boost event took place as early as 1 h, supporting the idea that this effect occurs at translational level ([Figure 3](#F3){ref-type="fig"}C inset). These results along with the ones depicted in [Figure 3](#F3){ref-type="fig"}(A) suggest that the main bulk of 15S rRNA could be in transit, stabilized by Ccm1p. Thus, this system might be a powerful tool to study mitoribosome assembly.

Finally, the transient nature of the first boost ([Figure 3](#F3){ref-type="fig"}C) suggests that bI4 maturase is under a high turnover. In agreement with this observation, Western blotting analysis of the boost revealed that while a major form of \~55 kDa was visualized at *t*=0, a\~75 kDa form, consistent with the full-length molecule appeared at 3 h when the boost took place ([Figure 3](#F3){ref-type="fig"}D). In addition to the \~55 kDa molecule, other species of lower molecular mass were also visualized when crude extracts were prepared in the presence of high concentration of protease inhibitors. Therefore the boost might overcome this high turnover of bI4 maturase, making visible the 75 kDa full-length form. We observed a unique \~30 kDa band when crude extracts from the very same samples were prepared without protease inhibitors. Thus, the previously described \~30 kDa fragment with maturase activity corresponding to the protein C-terminal end \[[@B7]\] could probably be a degradation product rather than a physiological form. We conclude that the SMDC strategy that yielded the central line of experimental evidence also introduces an improved system to dissect *in vivo* molecular interactions that, otherwise, would be considered cause--effect events.

The three lysine residues of Ccm1p PPR2 are required for full bI4 maturase activity but not to maintain 15S rRNA levels
-----------------------------------------------------------------------------------------------------------------------

The *CCM1* ORF lacking PPR2, which is the most canonical motif in the full length Ccm1p, complemented neither B \[[@B14]\] nor I^0^ Δ*ccm1* segregants (J. I. Moreno and M.A. Piva, unpublished work). Based on the role of positive charges in these motifs \[[@B23]\], we cumulatively replaced the three lysines of PPR2 (between amino acids 356 and 390) by alanine residues. No difference between bI4 maturase activity and 15S rRNA levels was observed in B Δ*ccm1* segregants complemented by single Lys^369^Ala or double Lys^369^Ala/Lys^375^Ala mutants in comparison with the wild-type ORF. However, a significant decrease in bI4 maturase activity along with a concomitant increase in bI4 maturase synthesis was observed in B Δ*ccm1* segregants complemented with triple-mutated Ccm1p (Lys^369^Ala/Lys^375^Ala/Lys^389^Ala, i.e. pCCM1LC-AAA) with respect to wild-type ORF (*P*\<0.05, [Figure 4](#F4){ref-type="fig"}). Cells harbouring wild-type and triple mutated ORFs expressed similar levels of *CCM1* mRNA. Importantly, no statistical differences in the activity of the other two maturases or the levels of 15S rRNA were detected between the triple-mutated and the wild-type ORFs (*P*\>0.05). These results contribute to identify which amino acids are involved in one of the activities \[[@B19]\] and provided the final line of evidence that characterizes, for the first time, Ccm1p as a PPR protein with moonlighting capabilities.

![Neutralization of lysine-positive charges in PPR2 differentially affects bI4 maturase activity\
RT-qPCR (maturase activities, *CCM1* mRNA and 15S rRNA levels) and ELISA (bI4 maturase protein) analyses of Δ*ccm1* B segregants harbouring vectors expressing the wild-type *CCM1* ORF (pYCCM1) and the triple mutant, Lys^369^, Lys^375^ and Lys^389^ to Ala (pYCCM1A3). Results are means±S.E.M. of duplicate or triplicate measurements of six independent experiments. Values of target mRNA from cells harbouring pYCCM1A3 were compared with those of the wild-type plasmid (pYCCM1) using the Student\'s *t* test.](bsr347i004){#F4}
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